Sciltp

Overview

Sciltp is a company that focuses on the publication of research articles, primarily in the field of clinical neuropsychopharmacology and addiction. Their recent documents include studies that explore the misuse of medications such as gabapentin and pregabalin, particularly in relation to their associated risks and trends in Scotland from 2000 to 2024. The research emphasizes the increasing concerns surrounding polypharmacy, especially when these substances are combined with other central nervous system depressants. Key findings from their studies indicate a significant rise in deaths linked to these medications, highlighting the importance of cautious prescribing practices and awareness of potential harms. The articles are characterized by a detailed analysis of socio-demographic factors, causes of death, and the implications of drug interactions. Overall, Sciltp's publications contribute to the understanding of drug misuse and its consequences, aiming to inform healthcare practices and policy regarding the safe use of psychoactive substances.